386 related articles for article (PubMed ID: 11910573)
1. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt.
Russo MW; Jacques PF; Mauro M; Odell P; Brown RS
Liver Transpl; 2002 Mar; 8(3):271-7. PubMed ID: 11910573
[TBL] [Abstract][Full Text] [Related]
2. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
[TBL] [Abstract][Full Text] [Related]
3. Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding.
Bañares R; Casado M; Rodríguez-Láiz JM; Camúñez F; Matilla A; Echenagusía A; Simó G; Piqueras B; Clemente G; Cos E
Am J Gastroenterol; 1998 Jan; 93(1):75-9. PubMed ID: 9448179
[TBL] [Abstract][Full Text] [Related]
4. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality.
Russo MW; Sood A; Jacobson IM; Brown RS
Am J Gastroenterol; 2003 Nov; 98(11):2521-7. PubMed ID: 14638358
[TBL] [Abstract][Full Text] [Related]
5. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
6. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study.
Domagk D; Patch D; Dick R; Grosso M; Rousseau H; Otal P; Goffette P; Heinecke A; Drees M; Domschke W; Menzel J
Cardiovasc Intervent Radiol; 2002; 25(6):506-12. PubMed ID: 12183763
[TBL] [Abstract][Full Text] [Related]
7. A case-control study of transjugular intrahepatic portosystemic stent shunts for patients admitted to intensive care following variceal bleeding.
Corbett C; Murphy N; Olliff S; Mangat KS; Tripathi D
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):344-51. PubMed ID: 23354162
[TBL] [Abstract][Full Text] [Related]
8. TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year period.
Gaba RC; Omene BO; Podczerwinski ES; Knuttinen MG; Cotler SJ; Kallwitz ER; Berkes JL; Walzer NM; Bui JT; Owens CA
J Vasc Interv Radiol; 2012 Feb; 23(2):227-35. PubMed ID: 22178037
[TBL] [Abstract][Full Text] [Related]
9. Factors predicting survival after transjugular intrahepatic portosystemic shunt creation: 15 years' experience from a single tertiary medical center.
Pan JJ; Chen C; Caridi JG; Geller B; Firpi R; Machicao VI; Hawkins IF; Soldevila-Pico C; Nelson DR; Morelli G
J Vasc Interv Radiol; 2008 Nov; 19(11):1576-81. PubMed ID: 18789725
[TBL] [Abstract][Full Text] [Related]
10. Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites.
Harrod-Kim P; Saad WE; Waldman D
J Vasc Interv Radiol; 2006 Oct; 17(10):1605-10. PubMed ID: 17057001
[TBL] [Abstract][Full Text] [Related]
11. Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation.
Abouljoud M; Yoshida A; Kim D; Jerius J; Arenas J; Raoufi M; Brown K; Moonka D
Transplant Proc; 2005 Mar; 37(2):1248-50. PubMed ID: 15848685
[TBL] [Abstract][Full Text] [Related]
12. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
Ochs A; Rössle M; Haag K; Hauenstein KH; Deibert P; Siegerstetter V; Huonker M; Langer M; Blum HE
N Engl J Med; 1995 May; 332(18):1192-7. PubMed ID: 7700312
[TBL] [Abstract][Full Text] [Related]
13. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
14. Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy.
Kochar N; Tripathi D; Ireland H; Redhead DN; Hayes PC
Gut; 2006 Nov; 55(11):1617-23. PubMed ID: 16571635
[TBL] [Abstract][Full Text] [Related]
15. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
Saad WE; Darwish WM; Davies MG; Waldman DL
J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
[TBL] [Abstract][Full Text] [Related]
16. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
[TBL] [Abstract][Full Text] [Related]
17. Transjugular intrahepatic portosystemic shunt for liver transplantation.
Zhou GW; Cai WY; Li HW; Zhu Y; Dodson F; Fung JJ
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):179-82. PubMed ID: 14607734
[TBL] [Abstract][Full Text] [Related]
18. Transjugular intrahepatic portosystemic shunts: long-term patency and clinical results in a patient cohort observed for 3-9 years.
ter Borg PC; Hollemans M; Van Buuren HR; Vleggaar FP; Groeneweg M; Hop WC; Laméris JS
Radiology; 2004 May; 231(2):537-45. PubMed ID: 15044746
[TBL] [Abstract][Full Text] [Related]
19. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial.
Henderson JM; Boyer TD; Kutner MH; Galloway JR; Rikkers LF; Jeffers LJ; Abu-Elmagd K; Connor J;
Gastroenterology; 2006 May; 130(6):1643-51. PubMed ID: 16697728
[TBL] [Abstract][Full Text] [Related]
20. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.
Malinchoc M; Kamath PS; Gordon FD; Peine CJ; Rank J; ter Borg PC
Hepatology; 2000 Apr; 31(4):864-71. PubMed ID: 10733541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]